HomeNewsOpinionUS-China tech war: Beijing calls for biopharmaceuticals dominance, lures talent back home

US-China tech war: Beijing calls for biopharmaceuticals dominance, lures talent back home

While the US semiconductor-control curbs seek to starve China of talent in this field, the CPC may be tempted to lure Chinese-Americans with US citizenship who are in important technical positions back in Chinese chip companies

November 24, 2022 / 12:10 IST
Story continues below Advertisement
The Joe Biden administration has intensified its onslaught on two elements that powered China’s rise: technology and capital. (File image)
The Joe Biden administration has intensified its onslaught on two elements that powered China’s rise: technology and capital. (File image)

The technology war between China and the United States (US) was reflected during the 20th Party Congress. Days before the Communist Party of China’s (CPC) quinquennial conclave, which charts the nation’s policy trajectory, America made it tougher for China to access semiconductors and the equipment that helps in its manufacture, but more importantly, it barred American nationals from working for a Chinese entity involved in its manufacture or proffering technical knowhow.

Tech-tonic Tussle

Story continues below Advertisement

The American Department of Defense is augmenting the investment blacklist for its citizens to include more Chinese companies, which are suspected to have ties to the People’s Liberation Army (PLA). This means US citizens will not be permitted to purchase or sell publicly traded securities in companies such as DJI Technology and Zhejiang Dahua Technology which manufacture drones and surveillance kits respectively and CRRC Corporation Ltd. which makes railway transit equipment. It also includes  BGI Genomics Co Ltd which manages a large gene databank.

Around 50 Chinese companies including telecommunications major, Huawei, along with companies such as  Semiconductor Manufacturing International Corporation (SMIC) had been added to the blacklist in June 2021. Through this, the US seeks to counter China’s military-civilian fusion strategy, which seeks to aid PLA’s modernisation by ensuring access to sophisticated technology with private firms playing the conduit. Thus, the Biden administration has intensified its onslaught on two elements that powered China’s rise: technology and capital.